A review of familial, genetic, and congenital aspects of primary varicose vein disease

Circulation: Cardiovascular Genetics

Volumn 5, Issue 4, 2012, Pages 460-466

  Anwar, Muzaffar A ^a   Georgiadis, Kyrillos Adesina ^b   Shalhoub, Joseph ^a   Lim, Chung S ^a   Gohel, Manjit S ^a   Davies, Alun H ^a  

^a CHARING CROSS HOSPITAL   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Congenital; Familial; Genetics; Hereditary; Varicose veins; Venous ulcers

Indexed keywords

BLOOD CLOTTING FACTOR 13; FIBROBLAST GROWTH FACTOR RECEPTOR 2; MACROPHAGE ELASTASE; MESSENGER RNA; NOTCH3 RECEPTOR; THROMBOMODULIN; TRANSCRIPTION FACTOR FOXC2;

ANGIOOSTEOHYPERTROPHY SYNDROME; CADASIL; CASE CONTROL STUDY; CHROMOSOME ABERRATION; CHRONIC VEIN INSUFFICIENCY; CHUVASH POLYCYTHEMIA; DISEASE ASSOCIATION; DISEASE SEVERITY; EHLERS DANLOS SYNDROME; FAMILY HISTORY; GENE EXPRESSION; GENE MUTATION; GENETIC SUSCEPTIBILITY; HERITABILITY; HUMAN; LYMPHEDEMA DISTICHIASIS; NEUTROPENIA; PEDIGREE ANALYSIS; POLYCYTHEMIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; REVIEW; RISK FACTOR; RNA INTERFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC REVIEW; THROMBOSIS; ULCER HEALING; VARICOSIS; VASCULAR SMOOTH MUSCLE; VENOUS THROMBOEMBOLISM;

FAMILY HEALTH; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INHERITANCE PATTERNS; MUTATION; VARICOSE ULCER; VARICOSE VEINS;

EID: 84868612528     PISSN: 1942325X     EISSN: 19423268     Source Type: Journal    
DOI: 10.1161/CIRCGENETICS.112.963439     Document Type: Review

References (72)

1. Lim CS, Davies AH. Pathogenesis of primary varicose veins. Br J Surg. 2009;96:1231-1242.
2. Bradbury A, Evans C, Allan P, Lee A, Ruckley C V, Flowkes FG. What are the symptoms of varicose veins? Edinburgh vein study cross sectional population survey. BMJ. 1999;318:353-356. (Pubitemid 29192081)
3. Robertson L, Evans C, Flowkes FG. Epidemiology of chronic venous disease. Phlebology. 2008;23:103-111.
4. Beebe-Dimmer JL, Pfeifer JR, Engle JS, Schottenfibro D. The epidemiology of chronic venous insufficiency and varicose veins. Ann Epidemiol. 2005;15:175-184. (Pubitemid 40269465)
5. Coon WW, Willis PW III, Keller JB. Venous thromboembolism and other venous disease in the Tecumseh community health study. Circulation. 1973;48:839-846.
6. Sisto T, Reunanen A, Laurikka J, Impivaara O, Heliovaara M, Knekt P, et al. Prevalence and risk factors of varicose veins in lower extremities: mini-Finland health survey. Eur J Surg. 1995;161:405-414.
7. Brand FN, Dannenberg AL, Abbott RD, Kannel WB. The epidemiology of varicose veins: the Framingham study. Am J Prev Med. 1988;4:96-101.
8. Fiebig A, Krusche P, Wolf A, Krawczak M, Timm B, Nikolaus S, et al. Heritability of chronic venous disease. Hum Genet. 2010;127:669-674.
9. Laurikka JO, Sisto T, Tarkka MR, Auvinen O, Hakama M. Risk indicators for varicose veins in forty-to sixty-year-olds in the Tampere varicose vein study. World J Surg. 2002;26:648-651. (Pubitemid 36920336)
10. Evans CJ, Flowkes FG, Ruckley CV, Lee AJ. Prevalence of varicose veins and chronic venous insufficiency in men and women in the general population: Edinburgh vein study. J Epidemiol Community Health. 1999;53:149-153. (Pubitemid 29086297)
11. Guberan E, Widmer LK, Glaus L, Muller R, Rougemont A, Da Silva A, et al. Causative factors of varicose veins: myths and facts. an epidemio-logical study of 610 women. Vasa. 1973;2:115-120.
12. Bell CG, Walley AJ, Froguel P. The genetics of human obesity. Nat Rev Genet. 2005;6:221-234. (Pubitemid 40293032)
13. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700.
14. Hirai M, Naiki K, Nakayama R. Prevalence and risk factors of varicose veins in Japanese women. Angiology. 1990;41:228-232. (Pubitemid 20095400)
15. Scott TE, La Morte WW, Gorin DR, Menzoian JO. Risk factors for chronic venous insufficiency: a dual case-control study. J Vasc Surg. 1995;22:622-628.
16. Ahti TM, Makivaara LA, Luukkaala T, Hakama M, Laurikka JO. Effect of family history on the risk of varicose veins is affected by differential misclassification. J Clin Epidemiol. 2010;63:686-690.
17. Cornu-Thenard A, Boivin P, Baud JM, De Vincenzi I, Carpentier PH. Importance of the familial factor in varicose disease. Clinical study of 134 families. J Dermatol Surg Oncol. 1994;20:318-326. (Pubitemid 24177257)
18. Brinsuk M, Tank J, Luft FC, Busjahn A, Jordan J. Heritability of venous function in humans. Arterioscler Thromb Vasc Biol. 2004;24:207-211. (Pubitemid 38082435)
19. Raffetto JD, Qiao X, Koledova VV, Khalil RA. Prolonged increases in vein wall tension increase matrix metalloproteinases and decrease constriction in rat vena cava: potential implications in varicose veins. J Vasc Surg. 2008;48:447-456.
20. Venturi M, Bonavina L, Annoni F, Colombo L, Butera C, Peracchia A, et al. Biochemical assay of collagen and elastin in the normal and varicose vein wall. J Surg Res. 1996;60:245-248. (Pubitemid 26044325)
21. Mizuno Y, Puca AA, O'Brien KF, Beggs AH, Kunkel LM. Genomic organization and single-nucleotide polymorphism map of desmuslin, a novel intermediate filament protein on chromosome 15q26.3. BMC Genet. 2001;2:8.
22. Yin H, Zhang X, Wang J, Yin W, Zhang G, Wang S, et al. Downregulation of desmuslin in primary vein incompetence. J Vasc Surg. 2006;43:372-378. (Pubitemid 43221936)
23. Wali MA, Eid RA. Smooth muscle changes in varicose veins: an ultra-structural study. J Smooth Muscle Res. 2001;37:123-135. (Pubitemid 34456771)
24. Urbanek T, Skop B, Wiaderkiewicz R, Wilczok T, Ziaja K, Lebda-Wyborny T, et al. Smooth muscle cell apoptosis in primary varicose veins. Eur J Vasc Endovasc Surg. 2004;28:600-611. (Pubitemid 39462651)
25. Xiao Y, Huang Z, Yin H, Lin Y, Wang S. In vitro differences between smooth muscle cells derived from varicose veins and normal veins. J Vasc Surg. 2009;50:1149-1154.
26. Xiao Y, Huang Z, Yin H, Zhang H, Wang S. Desmuslin gene knockdown causes altered expression of phenotype markers and differentiation of saphenous vein smooth muscle cells. J Vasc Surg. 2010;52:684-690.
27. Le Flem L, Mennen L, Aubry ML, Aiach M, Scarabin PY, Emmerich J, et al. Thrombomodulin promoter mutations, venous thrombosis, and varicose veins. Arterioscler Thromb Vasc Biol. 2001;21:445-451. (Pubitemid 32199129)
28. Lee S, Lee W, Choe Y, Kim D, Na G, Im S, et al. Gene expression profles in varicose veins using complementary DNA microarray. Dermatol Surg. 2005;31:391-395. (Pubitemid 40489297)
29. Parkes-Weber F. Angioma formation in connection with hypertrophy of limbs and hemi-hypertrophy. Br J Dermatol Syph. 1907;19:231-235.
30. Kihiczak GG, Meine JG, Schwartz RA, Janniger CK. Klippel-Trenaunay syndrome: a multisystem disorder possibly resulting from a pathogenic gene for vascular and tissue overgrowth. Int J Dermatol. 2006;45:883-890. (Pubitemid 44145020)
31. Lorda-Sanchez I, Prieto L, Rodriguez-Pinilla E, Martinez-Frias ML. Increased parental age and number of pregnancies in Klippel-Trenaunay-Weber syndrome. Ann Hum Genet. 1998;62:235-239. (Pubitemid 28468154)
32. Wang Q, Timur AA, Szafranski P, Sadgephour A, Jurecic V, Cowell J, et al. Identification and molecular characterization of de novo translocation t (8;14) (q22.3;q13) associated with a vascular and tissue overgrowth syndrome. Cytogenet Cell Genet. 2001;95:183-188. (Pubitemid 34638956)
33. Tian XL, Kadaba R, You SA, Liu M, Timur AA, Yang L, et al. Identification of an angiogenic factor that when mutated causes susceptibility to Klippel-Trenaunay syndrome. Nature. 2004;427:640-645. (Pubitemid 38248484)
34. Baskerville PA, Ackroyd JS, Browse NL. The etiology of the Klippel-Trenaunay syndrome. Ann Surg. 1985;202:624-627. (Pubitemid 16245047)
35. Servelle M. Klippel and Trenaunay's syndrome. 768 operated cases. Ann Surg. 1985;201:365-373. (Pubitemid 15010467)
36. Howlett DC, Roebuck DJ, Frazer CK, Ayers B. The use of ultrasound in the venous assessment of lower limb Klippel-Trenaunay syndrome. Eur J Radiol. 1994;18:224-226. (Pubitemid 24287200)
37. Temple IK, Collin JR. Distichiasis-lymphoedema syndrome: a family report. Clin Dysmorphol. 1994;3:139-142. (Pubitemid 24138132)
38. Fang J, Dagenais SL, Erickson RP, Arlt MF, Glynn MW, Gorski JL, et al. Mutations in FOXC2 (MFH-1), a forkhead family transcription factor, are responsible for the hereditary lymphedema-distichiasis syndrome. Am J Hum Genet. 2000;67:1382-1388.
39. Petrova TV, Karpanen T, Norrmen C, Mellor R, Tamakoshi T, Finegold D, et al. Defective valves and abnormal mural cell recruitment underlie lymphatic vascular failure in lymphedema distichiasis. Nat Med. 2004;10:974-981. (Pubitemid 39273739)
40. Dagenais SL, Hartsough RL, Erickson RP, Witte MH, Butler MG, Glover TW. FOXC2 is expressed in developing lymphatic vessels and other tissues associated with lymphedema-distichiasis syndrome. Gene Expr Patterns. 2004;4:611-619. (Pubitemid 39307524)
41. Erickson RP, Dagenais SL, Caulder MS, Downs CA, Herman G, Jones MC, et al. Clinical heterogeneity in lymphoedema-distichiasis with FOXC2 truncating mutations. J Med Genet. 2001;38:761-766. (Pubitemid 33032931)
42. Bell R, Brice G, Child AH, Murday VA, Mansour S, Sandy CJ, et al. Analysis of lymphoedema-distichiasis families for FOXC2 mutations reveals small insertions and deletions throughout the gene. Hum Genet. 2001;108:546-551. (Pubitemid 32700358)
43. Brice G, Mansour S, Bell R, Collin JR, Child AH, Brady AF, et al. Analysis of the phenotypic abnormalities in lymphoedema-distichiasis syndrome in 74 patients with FOXC2 mutations or linkage to 16q24. J Med Genet. 2002;39:478-483. (Pubitemid 34787740)
44. Ng MY, Andrew T, Spector TD, Jeffery S. Linkage to the FOXC2 region of chromosome 16 for varicose veins in otherwise healthy, unselected sibling pairs. J Med Genet. 2005;42:235-239. (Pubitemid 40380304)
45. Mellor RH, Brice G, Stanton AW, French J, Smith A, Jeffery S, et al. Mutations in FOXC2 are strongly associated with primary valve failure in veins of the lower limb. Circulation. 2007;115:1912-1920. (Pubitemid 46598905)
46. Saiki S, Sakai K, Saiki M, Kitagawa Y, Umemori T, Murata K, et al. Varicose veins associated with CADASIL result from a novel mutation in the Notch3 gene. Neurology. 2006;67:337-339. (Pubitemid 44305431)
47. Polyyakova LA. Familial-hereditary erythrocytosis. 1977; Moscow, Russia: Scientific Research Institute of Hematology and Blood Transfusion.
48. Ang SO, Chen H, Hirota K, Gordeuk VR, Jelinek J, Guan Y, et al. Disruption of oxygen homeostasis underlies congenital Chuvash polycy-themia. Nat Genet. 2002;32:614-621. (Pubitemid 35435173)
49. Semenza GL. Hypoxia-inducible factor 1: control of oxygen homeostasis in health and disease. Pediatr Res. 2001;49:614-617. (Pubitemid 32390848)
50. Gordeuk VR, Sergueeva AI, Miasnikova GY, Okhotin D, Voloshin Y, Choyke PL, et al. Congenital disorder of oxygen sensing: association of the homozygous Chuvash polycythemia VHL mutation with thrombosis and vascular abnormalities but not tumors. Blood. 2004;103:3924-3932. (Pubitemid 38596314)
51. Banka S, Chervinsky E, Newman WG, Crow YJ, Yeganeh S, Yacobovich J, et al. Further delineation of the phenotype of severe congenital neu-tropenia type 4 due to mutations in G6PC3. Eur J Hum Genet. 2011;19:18-22.
52. Scappaticci S, Capra E, Cortinovis M, Cortinovis R, Arbustini E, Diegoli M, et al. Cytogenetic studies in venous tissue from patients with varicose veins. Cancer Genet Cytogenet. 1994;75:26-30. (Pubitemid 24241106)
53. Zamboni P, Gemmati D. Clinical implications of gene polymorphisms in venous leg ulcer: a model in tissue injury and reparative process. Thromb Haemost. 2007;98:131-137. (Pubitemid 47074189)
54. Tognazzo S, Gemmati D, Palazzo A, Catozzi L, Carandina S, Legnaro A, et al. Prognostic role of factor XIII gene variants in nonhealing venous leg ulcers. J Vasc Surg. 2006;44:815-819. (Pubitemid 44441768)
55. Hoekstra KA, Godin DV, Cheng KM. Protective role of heme oxyge-nase in the blood vessel wall during atherogenesis. Biochem Cell Biol. 2004;82:351-359. (Pubitemid 39037114)
56. Zamboni P, Izzo M, Tognazzo S, Carandina S, De Palma M, Catozzi L, et al. The overlapping of local iron overload and HFE mutation in venous leg ulcer pathogenesis. Free Radic Biol Med. 2006;40:1869-1873.
57. Sam RC, Burns PJ, Hobbs SD, Marshall T, Wilmink AB, Silverman SH, et al. The prevalence of hyperhomocysteinemia, methylene tetrahydrofo-late reductase C677T mutation, and vitamin B12 and folate deficiency in patients with chronic venous insufficiency. J Vasc Surg. 2003;38:904-908. (Pubitemid 37409620)
58. Sverdlova AM, Bubnova NA, Baranovskaya SS, Vasina VI, Avitisjan AO, Schwartz EI. Prevalence of the methylenetetrahydrofolate reductase (MTHFR) C677T mutation in patients with varicose veins of lower limbs. Mol Genet Metab. 1998;63:35-36. (Pubitemid 28455925)
59. Gemmati D, Federici F, Catozzi L, Gianesini S, Tacconi G, Scapoli GL, et al. DNA-array of gene variants in venous leg ulcers: detection of prognostic indicators. J Vasc Surg. 2009;50:1444-1451.
60. Nagy N, Szolnoky G, Szabad G, Bata-Csorgo Z, Dobozy A, Kemeny L, et al. Single nucleotide polymorphisms of the fibroblast growth factor receptor 2 gene in patients with chronic venous insufficiency with leg ulcer. J Invest Dermatol. 2005;124:1085-1088. (Pubitemid 40629118)
61. Manolio TA, Collins FS, Cox NJ, Goldstein DB, Hindorff LA, Hunter DJ, et al. Finding the missing heritability of complex diseases. Nature. 2009;461:747-753.
62. Nicolaides AN, Allegra C, Bergan J, Bradbury A, Cairols M, Carpentier P, et al. Management of chronic venous disorders of the lower limbs: guidelines according to scientific evidence. Int Angiol. 2008;27:1-59. (Pubitemid 351523668)
63. Criqui MH, Jamosmos M, Fronek A, Denenberg JO, Langer RD, Bergan J, et al. Chronic venous disease in an ethnically diverse population: the San Diego population study. Am J Epidemiol. 2003;158:448-456. (Pubitemid 37022843)
64. Meissner MH, Gloviczki P, Bergan J, Kistner RL, Morrison N, Pannier F, et al. Primary chronic venous disorders. J Vasc Surg. 2007;46(suppl S):54S-67S.
65. Tsang FJ, Davies AH. Incomplete saphenopopliteal ligation after short sa-phenous vein surgery: a summation analysis. Phlebology. 2005;20:106-109. (Pubitemid 41433822)
66. Zeggini E, Weedon MN, Lindgren CM, Frayling TM, Elliott KS, Lango H, et al. Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science. 2007;316:1336-1341. (Pubitemid 46871654)
67. Tomlinson IP, Webb E, Carvajal-Carmona L, Broderick P, Howarth K, Pittman AM, et al. A genome-wide association study identifies colorectal cancer susceptibility loci on chromosomes 10p14 and 8q23.3. Nat Genet. 2008;40:623-630. (Pubitemid 351601204)
68. Brindle JT, Antti H, Holmes E, Tranter G, Nicholson JK, Bethell HW, et al. Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics. Nat Med. 2002;8:1439-1444. (Pubitemid 36019430)
69. Nicholson JK, Connelly J, Lindon JC, Holmes E. Metabonomics: a platform for studying drug toxicity and gene function. Nat Rev Drug Discov. 2002;1:153-161. (Pubitemid 41646523)
70. Nicholson G, Rantalainen M, Maher AD, Li JV, Malmodin D, Ahmadi KR, et al. Human metabolic profles are stably controlled by genetic and environmental variation. Mol Syst Biol. 2011;7:525.
71. Dumas ME, Wilder SP, Bihoreau MT, Barton RH, Fearnside JF, Argoud K, et al. Direct quantitative trait locus mapping of mammalian metabolic phenotypes in diabetic and normoglycemic rat models. Nat Genet. 2007;39:666-672. (Pubitemid 46676110)
72. Cazier JB, Kaisaki PJ, Argoud K, Blaise BJ, Veselkov K, Ebbels TM, et al. Untargeted metabolome quantitative trait locus mapping associates variation in urine glycerate to mutant glycerate kinase. J Proteome Res. 2012;11:631-642.